Pfizer (PFE) Change in Intangibles (2013 - 2020)

Pfizer (PFE) has 8 years of Change in Intangibles data on file, last reported at $38.0 million in Q3 2020.

• Change in Intangibles for Q3 2020 came in at $38.0 million, down 60.82% year-over-year; the trailing twelve-month figure through Sep 2020 was $125.0 million (down 73.35% YoY), and the FY2020 annual result was $539.0 million, up 28.95% from the prior year.
• Change in Intangibles grew to $38.0 million in Q3 2020 per PFE's latest filing, from $1.0 million in the prior quarter.
• Over five years, Change in Intangibles peaked at $158.0 million in Q1 2019 and troughed at $1.0 million in Q2 2020.
• A 5-year average of $74.1 million and a median of $76.5 million in 2016 frame the typical range for Change in Intangibles.
• The sharpest annual moves came in 2016 and 2020: Change in Intangibles surged 1820.0% in 2016, then plunged 99.08% in 2020.
• A 5-year view of Change in Intangibles shows it stood at $80.0 million in 2016, then dropped by 8.75% to $73.0 million in 2017, then soared by 43.84% to $105.0 million in 2018, then plunged by 48.57% to $54.0 million in 2019, then fell by 29.63% to $38.0 million in 2020.
• Business Quant data shows PFE's Change in Intangibles at $38.0 million in Q3 2020, $1.0 million in Q2 2020, and $32.0 million in Q1 2020.